Antiviral drugs help Gilead post higher profit

BOSTON (MarketWatch) - Gilead Sciences, Inc. on Tuesday said increased sales of its antiviral drugs helped the company post a strong jump in first-quarter profit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.